Boston, MA 04/02/2014 (wallstreetpr) – Intuitive Surgical, Inc. (NASDAQ:ISRG) shares jumped Tuesday on news that regulators had approved the company’s new version of robotic surgical system. The company announced that the U.S. Food and Drug Administration cleared da Vinci Xi, its latest surgery robotics which brings more power and enhancement to surgeons. da Vinci Xi features instruments which offer greater reach, new joint designs which improve the range of motion and instrument overhead that allow access from different positions. The da Vinci robotics are used by doctors to perform tiny incision surgery and are best applied in urology, thoracic and heart surgery procedures, where they have earned positive reputation. Nonetheless, questions have recently been raised over the cost of the da Vinci surgery robotics, where some experts have claimed that the system is too expensive. The Intuitive Surgical, Inc. (NASDAQ:ISRG) systems and instruments are usually replaced in each procedure. Shares jumped 12.7 percent by closing bell.
Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) benefited from a confusion arising from the Oculus name after Facebook Inc (NASDAQ:FB) acquired a company with a similar name last week. However, the company was able to bring forth its own positive news that has helped to power the stock. Last week OCLS announced a new member to its board of directors in the form of Sharon Barbari. The company CEO Jim Schutz observed that they hope to benefit from the mix of skills, knowledge and experience which Ms Barbari is bringing to the company’s board. The new board member, being currently the EVP and CFO at Cytokinetics Inc, possesses unrivalled hands-on experience in matters corporate finance and healthcare. Shares of Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) jumped more than 7 percent to perch at $4.04 during Tuesday trading.
Mattson Technology, Inc. (NASDAQ:MTSN) presents attractive play for investors seeking the positive side of semiconductor stocks. Following the announcement that the company expects to ship multiple Millios in the current, the news effectively removed fear over sector softness. It thus goes that the company will be able to achieve its target of Millios shipment this year. And analysts at Needham & Company and touting this fact as well with buy recommendation on the stock.